Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in severe influenza A infection
NCT02108366Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Mar 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in Influenza A (IAV), sponsored by The University of Hong Kong. Started Mar 2014; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02108366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108366.